Atlas Trials

Tezepelumab and Methacholine Airway Hyperresponsiveness in Participants With Mild Allergic Asthma

Clinical trial NCT05740748 · UNKNOWN

Trial details

NCT number
NCT05740748
Sponsor
McMaster University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Asthma, Allergic
Start date
2023-04-01
Primary completion
2024-12-30
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.